Quel est le prix pour BillionToOne, Inc. (BLLN)

Le prix pour BillionToOne, Inc. (BLLN) est $99.89

Quelle est la capitalisation boursière pour BillionToOne, Inc. (BLLN)

La capitalisation boursière pour BillionToOne, Inc. (BLLN) est $4.59B

BillionToOne, Inc. (BLLN) Dividendes

BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.

Année	Dividende (ajusté pour divisions d’actions)	Changez
Pas assez de données pour les dates fournies.

Année

Dividende (ajusté pour divisions d’actions)

Changez

Pas assez de données pour les dates fournies.

Année	Dividende	Changez
Pas assez de données pour les dates fournies.

Année

Dividende

Changez

Pas assez de données pour les dates fournies.

Entreprise	Nombre de paiements de dividendes	Pays
Thermo Fisher Scientific Inc. TMO.US	60.00%	US
Danaher Corporation DHR.US	134.00%	US
WuXi AppTec Co., Ltd. 603259.SS	0.00%	CN
Natera, Inc. NTRA.US	0.00%	US
Agilent Technologies, Inc. A.US	58.00%	US

Entreprise

Nombre de paiements de dividendes

Pays